Condition
Bimaxillar Surgery
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06933680Not ApplicableRecruitingPrimary
Sphenopalatine Ganglion Block in Bimaxillary Orthognathic Surgery
NCT04454866Not ApplicableCompleted
Penehyclidine for Prevention of Nausea and Vomiting After Bimaxillary Surgery
NCT04112771Completed
Penehyclidine and Postoperative Nausea and Vomiting After Bimaxillary Surgery
Showing all 3 trials